European Archives - Page 126 of 899 - European Medical Journal

Continue
8th December 2023

Horizons in Haematology: Insights from the EHA President

António Almeida joins us to discuss the EHA, modern medical education, and promising treatment advances.
8th December 2023

BIMZELX®▼ (bimekizumab) Mode of Action

Learn about the mechanism of action for Bimzelx (bimekizumab). To find out more, please visit www.bimzelx.eu…
7th December 2023

The Diverse Applications of Radiology

Refky Nicola joins Jonathan to discuss various uses of radiology and what the future holds for the discipline as technology continues to develop.
7th December 2023

ROCKETing Forward: The Future of Atopic Dermatitis Treatment Targeting the OX40 Signalling Pathway

View our latest infographic, which spotlights the challenges and opportunities for the treatment of atopic dermatitis (AD), highlighting…
7th December 2023

Complex High-risk Interventional Patients and Procedures: Case-based review and patient management.

We are pleased to bring you a roundtable discussion webinar exploring complex high-risk interventional procedures, including comprehensive discussion on a patient case and effective patient management strategies.
6th December 2023

Vitiligo Is an Immune Mediated Disease – Do We Have the Right Approach and Tools to Manage?

This two-part podcast series delves into vitiligo as a systemic disease, its known risk factors, and the stigma often associated with the condition.
4 Mins
6th December 2023

Interview: Maureen Kohi

Maureen Kohi – University of North Carolina (UNC) at Chapel Hill, USA. During medical school, I found myself gravitating towards…
1 Mins
6th December 2023

Children with Atopic Dermatitis More Likely to Develop Other Skin Conditions

Children with atopic dermatitis are more likely to develop other skin conditions. Despite this, researchers reported that many children with AD are not referred for patch testing, and ACD is often underdiagnosed.

A patient's right to thrive, not just survive

Listen to Isabel chatting with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb.
5th December 2023

ESMO 2023 Industry Sponsored Satellite Symposium: Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment with Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors

At the 2023 European Society for Medical Oncology (ESMO) Annual Congress, held in Madrid, Spain, Jürgen Wolf, University Hospital Cologne…